Adjuvant and neoadjuvant chemotherapy (NAC) with ifosfamide (IFO) and doxorubicin hydrochloride (ADM) for high-grade soft tissue sarcomas (STS) in the extremities: Japan Clinical Oncology Group study JCOG030404.

Clinical Oncology ◽

Soft Tissue Sarcomas ◽

High Grade ◽

Doxorubicin Hydrochloride ◽

Oncology Group ◽

Prognostic factors for high-grade soft tissue sarcomas (STS) in the extremities treated by perioperative chemotherapy with ifosfamide (IFO) and doxorubicin hydrochloride (ADM): Using the data from Japan Clinical Oncology Group trial (JCOG0304).

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.10577 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 10577-10577

Author(s):

Kazuhiro Tanaka ◽

Tadashi Hasegawa ◽

Junki Mizusawa ◽

Nobuhito Araki ◽

Hirokazu Chuuman ◽

...

Keyword(s):

Prognostic Factors ◽

Soft Tissue ◽

Clinical Oncology ◽

Soft Tissue Sarcomas ◽

High Grade ◽

Perioperative Chemotherapy ◽

Doxorubicin Hydrochloride ◽

Oncology Group ◽

Group Trial

Preoperative and Postoperative Chemotherapy with Ifosfamide and Adriamycin for Adult High-grade Soft-tissue Sarcomas in the Extremities: Japan Clinical Oncology Group Study JCOG0304

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyn153 ◽

2009 ◽

Vol 39 (4) ◽

pp. 271-273 ◽

Cited By ~ 18

Author(s):

K. Tanaka ◽

H. Kawamoto ◽

I. Saito ◽

K. Yoshimura ◽

H. Fukuda ◽

...

Keyword(s):

Soft Tissue ◽

Clinical Oncology ◽

Soft Tissue Sarcomas ◽

Postoperative Chemotherapy ◽

High Grade ◽

Oncology Group ◽

Prospective comparison of various radiological response criteria and pathological response to preoperative chemotherapy and survival in operable high-grade soft tissue sarcomas in the Japan Clinical Oncology Group study JCOG0304

World Journal of Surgical Oncology ◽

10.1186/s12957-018-1462-y ◽

2018 ◽

Vol 16 (1) ◽

Cited By ~ 3

Author(s):

Kazuhiro Tanaka ◽

Gakuto Ogawa ◽

Junki Mizusawa ◽

Norifumi Naka ◽

Akira Kawai ◽

...

Keyword(s):

Soft Tissue ◽

Clinical Oncology ◽

Soft Tissue Sarcomas ◽

Pathological Response ◽

High Grade ◽

Oncology Group ◽

Oncology Group Study ◽

Prospective Comparison ◽

Radiological Response

Prospective evaluation of Ki-67 system in histological grading of soft tissue sarcomas in the Japan Clinical Oncology Group Study JCOG0304

World Journal of Surgical Oncology ◽

10.1186/s12957-016-0869-6 ◽

2016 ◽

Vol 14 (1) ◽

Cited By ~ 9

Author(s):

Kazuhiro Tanaka ◽

Tadashi Hasegawa ◽

Takayuki Nojima ◽

Yoshinao Oda ◽

Junki Mizusawa ◽

...

Keyword(s):

Soft Tissue ◽

Clinical Oncology ◽

Soft Tissue Sarcomas ◽

Prospective Evaluation ◽

Oncology Group ◽

Histological Grading ◽

Ki 67 ◽

Ten-year follow-up results of perioperative chemotherapy with doxorubicin and ifosfamide for high-grade soft-tissue sarcoma of the extremities: Japan Clinical Oncology Group study JCOG0304

BMC Cancer ◽

10.1186/s12885-019-6114-2 ◽

2019 ◽

Vol 19 (1) ◽

Cited By ~ 4

Author(s):

Kazuhiro Tanaka ◽

Junki Mizusawa ◽

Norifumi Naka ◽

Akira Kawai ◽

Hirohisa Katagiri ◽

...

Keyword(s):

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Clinical Oncology ◽

High Grade ◽

Perioperative Chemotherapy ◽

Oncology Group ◽

A Randomized Phase II/III Trial of Perioperative Chemotherapy with Adriamycin Plus Ifosfamide Versus Gemcitabine Plus Docetaxel for High-grade Soft Tissue Sarcoma: Japan Clinical Oncology Group Study JCOG1306

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyu080 ◽

2014 ◽

Vol 44 (8) ◽

pp. 765-769 ◽

Cited By ~ 7

Author(s):

K. Kataoka ◽

K. Tanaka ◽

J. Mizusawa ◽

A. Kimura ◽

H. Hiraga ◽

...

Keyword(s):

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Clinical Oncology ◽

Phase Ii ◽

High Grade ◽

Perioperative Chemotherapy ◽

Oncology Group ◽

Oncology Group Study ◽

Randomized Phase Ii

Feasibility study of neoadjuvant chemotherapy followed by interval debulking surgery for stage III/IV ovarian, tubal, and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0206

Gynecologic Oncology ◽

10.1016/j.ygyno.2008.12.027 ◽

2009 ◽

Vol 113 (1) ◽

pp. 57-62 ◽

Cited By ~ 37

Author(s):

Takashi Onda ◽

Hiroaki Kobayashi ◽

Toru Nakanishi ◽

Masayuki Hatae ◽

Tsuyoshi Iwasaka ◽

...

Keyword(s):

Clinical Oncology ◽

Feasibility Study ◽

Stage Iii ◽

Oncology Group ◽

Debulking Surgery ◽

Oncology Group Study ◽

Interval Debulking Surgery

Diagnosis of invasion depth in resectable advanced gastric cancer for neoadjuvant chemotherapy: An exploratory analysis of Japan clinical oncology group study: JCOG1302A

European Journal of Surgical Oncology ◽

10.1016/j.ejso.2020.02.038 ◽

2020 ◽

Vol 46 (6) ◽

pp. 1074-1079

Author(s):

Yuya Sato ◽

Junki Mizusawa ◽

Hiroshi Katayama ◽

Kenichi Nakamura ◽

Takeo Fukagawa ◽

...

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Clinical Oncology ◽

Exploratory Analysis ◽

Oncology Group ◽

Invasion Depth ◽

A Randomized Controlled Trial Investigating the Survival Benefit of Dose-Intensified Multidrug Combination Chemotherapy (LSG9) for Intermediate- or High-Grade Non-Hodgkin's Lymphoma: Japan Clinical Oncology Group Study 9002

International Journal of Hematology ◽

10.1532/ijh97.04085 ◽

2004 ◽

Vol 80 (4) ◽

pp. 341-350 ◽

Cited By ~ 12

Author(s):

Tomohiro Kinoshita ◽

Tomomitsu Hotta ◽

Kensei Tobinai ◽

Tohru Kobayashi ◽

Naoki Ishizuka ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Clinical Oncology ◽

Combination Chemotherapy ◽

Survival Benefit ◽

Controlled Trial ◽

High Grade ◽

Oncology Group ◽

Oncology Group Study ◽

Randomized Controlled

Feasibility Study of Neoadjuvant Chemotherapy Followed by Interval Cytoreductive Surgery for Stage III/IV Ovarian, Tubal and Peritoneal Cancers: Japan Clinical Oncology Group Study JCOG0206

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyh007 ◽

2004 ◽

Vol 34 (1) ◽

pp. 43-45 ◽

Cited By ~ 7

Author(s):

T. Onda

Keyword(s):

Clinical Oncology ◽

Feasibility Study ◽

Cytoreductive Surgery ◽

Stage Iii ◽

Oncology Group ◽